Exact Sciences
EXAS
#1162
Rank
A$28.72 B
Marketcap
A$151.40
Share price
-0.05%
Change (1 day)
60.44%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

EPS for Exact Sciences (EXAS)

EPS in 2025 (TTM): A-$8.54

According to Exact Sciences's latest financial reports the company's current EPS (TTM) is A-$7.93. In 2024 the company made an earnings per share (EPS) of A-$8.30.

EPS history for Exact Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$8.542.83%
2024A-$8.30
2022A-$5.282.31%
2021A-$5.16-38.54%
2020A-$8.39692.96%
2019A-$1.06-50.69%
2018A-$2.1544%
2017A-$1.49-39.39%
2016A-$2.46-2.94%
2015A-$2.5337.1%
2014A-$1.8579.71%
2013A-$1.03-21.59%
2012A-$1.31

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Myriad Genetics
MYGN
A-$6.46-18.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
A$0.51-106.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Veracyte
VCYT
A$0.58-107.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
A-$75.89 856.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$5.53-169.66%๐Ÿ‡ซ๐Ÿ‡ท France